All News about Vir Biotechnology Inc
![](/next-assets/images/schema-image-default.png)
Earnings Outlook For Vir Biotechnology
February 21, 2024
Via Benzinga
![](https://mms.businesswire.com/media/20240220541768/en/1895639/22/VIR_logo_large_color.jpg)
![](https://investorplace.com/wp-content/uploads/2022/04/pte_biotech_1600-1024x576.png)
![](https://mms.businesswire.com/media/20240208205237/en/1895639/22/VIR_logo_large_color.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.png?width=1200&height=800&fit=crop)
JP Morgan Downgrades Vir Biotechnology: Here's What You Need To Know
January 29, 2024
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_2.jpeg?width=1200&height=800&fit=crop)
What 8 Analyst Ratings Have To Say About Vir Biotechnology
September 08, 2023
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_1.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/12/20/covid-19_vaccination-photo_by_johaehn_from_pixabay.jpg?width=1200&height=800&fit=crop)
![](https://mms.businesswire.com/media/20231213396441/en/1895639/22/VIR_logo_large_color.jpg)
![](https://mms.businesswire.com/media/20231206544466/en/1895639/22/VIR_logo_large_color.jpg)
![](https://investorplace.com/wp-content/uploads/2019/07/smallcap1600.jpg)
![](https://www.marketbeat.com/logos/articles/med_20231127074521_from-laggards-to-leaders-small-caps-on-the-rise.jpg)
![](https://mms.businesswire.com/media/20231110130371/en/1895639/22/VIR_logo_large_color.jpg)
![](https://mms.businesswire.com/media/20231106658171/en/1895639/22/VIR_logo_large_color.jpg)
![](https://mms.businesswire.com/media/20231106932182/en/1895639/22/VIR_logo_large_color.jpg)
![](https://mms.businesswire.com/media/20231101298972/en/1895639/22/VIR_logo_large_color.jpg)
![](https://mms.businesswire.com/media/20231026830042/en/1926904/5/Jen_Towne_Head_Shot_2023.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
![](https://investorplace.com/wp-content/uploads/2019/11/bill-gates.jpg)
![](https://investorplace.com/wp-content/uploads/2022/10/pill-bottle-biopharma-biotech-1600.jpg)
![](https://ml.globenewswire.com/media/90a16157-2d00-4b2f-93d8-82d3df30d2ec/small/vir-logo-large-color-jpg.jpg)
![](https://ml.globenewswire.com/media/90a16157-2d00-4b2f-93d8-82d3df30d2ec/small/vir-logo-large-color-jpg.jpg)
![](https://ml.globenewswire.com/media/90a16157-2d00-4b2f-93d8-82d3df30d2ec/small/vir-logo-large-color-jpg.jpg)
![](https://ml.globenewswire.com/media/90a16157-2d00-4b2f-93d8-82d3df30d2ec/small/vir-logo-large-color-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/09/27/joe_biden-photo_via_rawpixel.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/movers_image_1.jpeg?width=1200&height=800&fit=crop)
![](https://ml.globenewswire.com/media/90a16157-2d00-4b2f-93d8-82d3df30d2ec/small/vir-logo-large-color-jpg.jpg)
![](https://cdn.benzinga.com/files/images/story/2023/09/08/vir.png?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2023/analyst_ratings_image_4.png?width=1200&height=800&fit=crop)
Benzinga's Top Ratings Upgrades, Downgrades For September 8, 2023
September 08, 2023
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.